PCP
Phencyclidine, a cyclohexylamine derivative, is widely used in veterinary medicine to briefly immobilize large animals and is sometimes described as a dissociative anesthetic. PCP is easily synthesized and is abused, primarily by young people and polydrug users. The true extent of PCP abuse is unknown, but recent national surveys indicate an increase in frequency of use.
Phencyclidine is taken orally, by smoking, or by intravenous injection. It is also used as an adulterant in illicit sales of THC, LSD, amphetamine, or cocaine. The most common street preparation, “angel dust,” is a white granular powder which contains 50 to 100 percent of the drug. Low doses (5 mg) produce agitation, excitement, impaired motor coordination, dysarthria, and analgesia. Users may have horizontal or vertical nystagmus, flushing, diaphoresis, and hyperacusis. Behavioral changes include distortions of body image, disorganization of thinking, and feelings of estrangement. Higher doses of PCP (5 to 10 mg) may produce hypersalivation, vomiting, myoclonus, fever, stupor, or coma. PCP doses of 10 mg or more cause convulsions, opisthotonus, and decerebrate posturing which may be followed by prolonged coma.
The diagnosis of PCP overdose is difficult because the patient’s initial symptoms may suggest an acute schizophrenic reaction. Confirmation of PCP use is possible by determination of PCP levels in serum or urine. PCP analysis is currently available at most toxicologic centers. Large quantities of PCP remain in urine for 1 to 5 days following high-dosage PCP intake.
PCP overdose requires prompt life support measures including treatment of coma, convulsions, and respiratory depression in a hospital intensive care unit. There is no specific antidote or antagonist for PCP. PCP excretion from the body can be enhanced by acidification of urine and gastric lavage. Death from PCP overdose may occur as a consequence of some combination of pharyngeal hypersecretion, hyperthermia, respiratory depression, severe hypertension, seizures, hypertensive encephalop-athy, and intracerebral hemorrhage.
Acute psychosis associated with PCP use should be considered a psychiatric emergency since patients may be at high risk for suicide or extreme violence toward others. Phenothiazines should not be used for treatment of acute PCP psychosis because these drugs potentiate PCP’s anticholinergic effects. Haloperidol (5 mg intramuscularly) has been administered on an hourly basis to induce suppression of psychotic behavior. PCP, like LSD and mescaline, produces vasospasm of cerebral arteries at relatively low doses. Chronic PCP use has been shown to induce insomnia, anorexia, severe social and behavioral changes, and, in some cases, chronic schizophrenia.